3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Carcinoma
6
Lung Neoplasms
5
Nasopharyngeal Carcinoma
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma
1
Medulloblastoma
1
Locally Advanced Cervical Adenocarcinoma
1
Liver Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
28
enzalutamide
27
Specimen Handling
21
apalutamide
18
Androgen Antagonists
16
Prednisone
15
Abiraterone Acetate
15
Radiosurgery
13
abiraterone
11
Radiotherapy
10
Docetaxel
10
Biopsy
9
darolutamide
8
Pluvicto
8
Nivolumab
8
niraparib
6
cabazitaxel
6
Surveys and Questionnaires
6
Radiation
6
Lutetium-177
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
gallium 68 PSMA-11
5
bicalutamide
5
Radiotherapy, Intensity-Modulated
5
Lutetium
5
Gonadotropin-Releasing Hormone
5
radium Ra 223 dichloride
4
pembrolizumab
4
luprolide acetate gel depot
4
cabozantinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
30 days
×
Clear all
No trials found.